NASDAQ: IMVT · Life Sciences · 8 alerts · CIK 1764013
Share price
$33.28Close, Nov 16
Market cap
$6.89B
Shares outstanding
206.95MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Immunovant, Inc. filings on SEC EDGAR ↗
Immunovant Insider Atul Pande Sells $108K of Stock
Atul Pande sold 3,000 shares of Immunovant, Inc. at $36.00 a share, worth $108K in total on Nov 11, 2026. Shares held after the trade: 116,731 (-2.5%).
Tiago Girao, CFO, sold 6,606 shares of Immunovant, Inc. at $28.50 a share, worth $188K in total on Oct 28, 2026. Shares held after the trade: 234,192 (-2.7%).
Jay S. Stout, CTO, sold 3,809 shares of Immunovant, Inc. at $32.06 a share, worth $122K in total on Oct 7, 2026. Shares held after the trade: 201,532 (-0.8%).
Immunovant CLO Tuyl Christopher Van Sells $42.5K of Stock
Tuyl Christopher Van, CLO, sold 1,327 shares of Immunovant, Inc. at $32.06 a share, worth $42.5K in total on Oct 7, 2026. Shares held after the trade: 175,218 (-0.8%).
Immunovant COO Melanie Gloria Sells $71.8K of Stock
Melanie Gloria, COO, sold 2,241 shares of Immunovant, Inc. at $32.06 a share, worth $71.8K in total on Oct 7, 2026. Shares held after the trade: 217,060 (-1.0%).
Eric Venker, CEO, sold 3,506 shares of Immunovant, Inc. at $34.11 a share, worth $120K in total on Oct 2, 2026. Shares held after the trade: 257,075 (-1.3%).